|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 28, 2024
|
FY2023
12 months to Dec 30, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Jan 1, 2022
|
|
|---|---|---|---|---|---|
| Cash flows from operating activities | |||||
| Net income | |||||
| Adjustments to reconcile net income to net cash provided by operating activities: | |||||
| Depreciation and amortization | |||||
| Foreign exchange and other non-cash financing (income) expense | |||||
| Share-based compensation expense | |||||
| Decrease in postretirement benefit obligations, net | |||||
| Deferred income taxes | |||||
| Asset impairments | |||||
| Loss on deconsolidation of Russian subsidiary | |||||
| Disposal of property, plant and equipment | |||||
| Other operating activities | |||||
| Changes in operating assets and liabilities: | |||||
| —Accounts receivable | |||||
| —Inventories | |||||
| —Accounts payable | |||||
| —Prepaid expenses and other assets | |||||
| —Taxes payable | |||||
| —Other liabilities | |||||
| Net cash provided by operating activities | |||||
| Cash flows from investing activities | |||||
| Purchases of property, plant and equipment | |||||
| Purchases of intangible assets | |||||
| Purchases of investments | |||||
| Proceeds from sale of investments | |||||
| Cash paid under company-owned life insurance policies | |||||
| Cash received under company-owned life insurance policies | |||||
| Proceeds from the sale of property, plant and equipment | |||||
| Cash deconsolidated from previously controlled subsidiary | |||||
| Other investing activities | |||||
| Net cash used in investing activities | |||||
| Cash flows from financing activities | |||||
| Issuance of shares | |||||
| Repurchase of shares | |||||
| Proceeds from long-term debt | |||||
| Payments of long-term debt | |||||
| Debt issuance costs paid | |||||
| Employee taxes paid from shares withheld | |||||
| Dividends paid to non-controlling interests | |||||
| Other financing activities | |||||
| Net cash used in financing activities | |||||
| Effect of exchange rate changes on cash and cash equivalents and restricted cash | |||||
| Net increase (decrease) in cash and cash equivalents and restricted cash | |||||
| Cash and cash equivalents and restricted cash at the beginning of the period | |||||
| Cash and cash equivalents and restricted cash at the end of the period | |||||
| Supplemental schedule of cash flow information | |||||
| Interest paid | |||||
| Income taxes paid | |||||
| Accrued capital expenditures |
Loading...